Skip to main content
TipRanks
Go Ultimate75% OFF

Opko Health (XCY) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

XCY Analyst Ratings

Strong Buy
4Ratings
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Opko Health in the past 3 months

XCY Stock 12 Month Forecast

€2.80▲(89.01% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Opko Health in the last 3 months. The average price target is EUR 2.80 with a high forecast of EUR 3.63 and a low forecast of EUR 2.04. The average price target represents a 89.01% change from the last price of EUR 1.48.
Highest Price Target€3.63Average Price Target€2.80Lowest Price Target€2.04

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:XCY
Price TargetArticle
Barrington€2.04buy37.93%UpsideReiterated11/16/26
J.P. Morgan Analyst forecast on DE:XCYUnknown AnalystNot RankedJ.P. Morgan―hold―Reiterated11/09/26
H.C. Wainwright€1.81→€2.72buy83.90%UpsideReiterated11/05/26
Piper Sandler€3.63buy145.20%UpsideReiterated11/05/26
Ladenburg Thalmann & Co. Analyst forecast on DE:XCYUnknown AnalystNot RankedLadenburg Thalmann & Co.€2.72buy83.90%UpsideReiterated02/27/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Opko Health

3 Months
Michael Petusky
Michael PetuskyBarrington
Success Rate15/31 ratings generated profit
48%
Average Return
+9.16%

Copying Michael Petusky's trades and holding each position for 3 Months would result in 48.39% of your transactions generating a profit, with an average return of +9.16% per trade.

1 Year
Michael Petusky
Michael PetuskyBarrington
Success Rate13/31 ratings generated profit
42%
Average Return
+22.64%

Copying Michael Petusky's trades and holding each position for 1 Year would result in 41.94% of your transactions generating a profit, with an average return of +22.64% per trade.

2 Years
Michael Petusky
Michael PetuskyBarrington
Success Rate9/31 ratings generated profit
29%
Average Return
+7.93%

Copying Michael Petusky's trades and holding each position for 2 Years would result in 29.03% of your transactions generating a profit, with an average return of +7.93% per trade.

XCY Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for XCY
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy54345
Buy00012
Hold11101
Sell00000
Strong Sell00000
total65458

In the current month, XCY has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. XCY average Analyst price target in the past 3 months is 2.80.

XCY Financial Forecast

€-2€-1.5€-1€-0.5€0Q1 2026Q3 2026Q4 2026
High€-0.02
Consensus€-0.05
Low€-0.10

XCY Earnings Forecast

Next quarter’s earnings estimate for XCY is -EUR 0.05 with a range of -EUR 0.10 to -EUR 0.02. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€59.3M€81.6M€103.9M€126.1M€148.4MQ1 2026Q3 2026Q4 2026
High€63.5M
Consensus€61.3M
Low€59.7M

XCY Sales Forecast

Next quarter’s sales forecast for XCY is EUR 61.31M with a range of EUR 59.66M to EUR 63.51M. The previous quarter’s sales results were EUR 59.35M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

XCY Stock Forecast FAQ

What is DE:XCY’s average 12-month price target, according to analysts?
Based on analyst ratings, Opko Health’s 12-month average price target is €2.80.
What is DE:XCY’s upside potential, based on the analysts’ average price target?
Opko Health has 89.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Opko Health a Buy, Sell or Hold?
Opko Health has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Opko Health’s share price target?
The average share price target for Opko Health is €2.80. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €3.63, and the lowest forecast is €2.04. The average share price target represents a 89.01% increase from the current price of €1.48.
What do analysts say about Opko Health?
Opko Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Opko Health?
To buy shares of DE:XCY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.